BIBLIOS

  Sistema de Gestão de Referências Bibliográficas de Ciências

Modo Visitante (Login)
Need help?


Voltar

Detalhes Referência

Tipo
Capítulo em Livro


Título
Chapter 6 – New Inorganic Therapeutics I “Ruthenium and iron metallodrugs: new inorganic and organometallic complexes as prospective anticancer agents” in Synthetic Inorganic Chemistry – New perspectives

Participantes na publicação
Andreia Valente (Author)
Dep. Química e Bioquímica
CQE
Tânia S. Morais (Author)
Dep. Química e Bioquímica
Dep. Química e Bioquímica
CQE
Ricardo G. Teixeira (Author)
Cristina P. Matos (Author)
M. Helena Garcia (Author)
Dep. Química e Bioquímica
CQE
Ana Isabel Tomaz (Author)
Dep. Química e Bioquímica
CQE

Resumo
"Synthetic Inorganic Chemistry: New Perspectives" presents summaries of the work of some of the most creative researchers in the field. The book highlights the most novel approaches and burgeoning applications of synthetic inorganic chemistry in development. As the first volume in the Developments in Inorganic Chemistry series, this work is a valuable resource for students and researchers working in inorganic chemistry and material science.In this Chapter (6 - New Inorganic therapeutics, I) we address the development of ruthenium- and iron-based metallodrugs as prospective chemotherapeutics in cancer treatment. We provide an overview of the field addressing iron and ruthenium complexes reported as promising anti-cancer metallodrug candidates, on their properties and specific features, and mostly focus on newer contributions in this field which include ‘classical’ coordination complexes and organometallic compounds. The first group comprises Fe(III) and Ru(III) complexes with octahedral geometry and a tetradentate ligand, namely ternary tripodal aminobisphenolates and cyclam derivatives for Fe(III) or salen- and salan-like ligands for Ru(III). In the larger group of organometallic complexes, we highlight the value of the M(Cp) scaffold in metallodrug design (M being Ru(II) and Fe(II), Cp being eta5-cyclopentadienyl) and provide examples of very effective compounds with modes of action that are distinct from those of Pt-based drugs in clinical use, including some Ru(Cp) complexes with ability to overcome multidrug resistance mechanisms.

Editor
Ewan J. M. Hamilton

Data de Publicação
2021-04-17

Instituição
FACULDADE DE CIÊNCIAS DA UNIVERSIDADE DE LISBOA

Suporte
Elsevier

Identificadores da Publicação
ISBN - [eBook ISBN]: 9780128189337

Editora
Elsevier Inc.

Edição
1

Número de Páginas
54
Página Inicial
223
Página Final
276

Identificadores do Documento
DOI - https://doi.org/10.1016/B978-0-12-818429-5.00010-7
ISBN - 9780128184295
URL - https://www.elsevier.com/books/synthetic-inorganic-chemistry/hamilton/978-0-12-818429-5

Anotações
AIT: submitting author; corresponding author


Exportar referência

APA
Andreia Valente, Tânia S. Morais, Ricardo G. Teixeira, Cristina P. Matos, M. Helena Garcia, Ana Isabel Tomaz, (2021). Chapter 6 – New Inorganic Therapeutics I “Ruthenium and iron metallodrugs: new inorganic and organometallic complexes as prospective anticancer agents” in Synthetic Inorganic Chemistry – New perspectives. Elsevier, 223-276

IEEE
Andreia Valente, Tânia S. Morais, Ricardo G. Teixeira, Cristina P. Matos, M. Helena Garcia, Ana Isabel Tomaz, "Chapter 6 – New Inorganic Therapeutics I “Ruthenium and iron metallodrugs: new inorganic and organometallic complexes as prospective anticancer agents” in Synthetic Inorganic Chemistry – New perspectives" in Elsevier, 2021, pp. 223-276

BIBTEX
@incollection{49099, author = {Andreia Valente and Tânia S. Morais and Ricardo G. Teixeira and Cristina P. Matos and M. Helena Garcia and Ana Isabel Tomaz}, title = {Chapter 6 – New Inorganic Therapeutics I “Ruthenium and iron metallodrugs: new inorganic and organometallic complexes as prospective anticancer agents” in Synthetic Inorganic Chemistry – New perspectives}, booktitle = {Elsevier}, year = 2021, pages = {223-276}, address = {}, publisher = {Elsevier Inc.} }